ANTIESTROGEN AND ANTIANDROGEN ADMINISTRATION REDUCE BONE MASS IN THE RAT

[31] LINDSAY R, 1980, LANCET, V2, P1151

[32] LINDSAY R, 1978, POSTGRAD MED J, V54, P50

[33] METABOLISM OF TAMOXIFEN AND ITS UTEROTROPHIC ACTIVITY [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (15) : 2787 - 2794

[34] OSTEOBLASTIC INSUFFICIENCY IS RESPONSIBLE FOR MAINTENANCE OF OSTEOPENIA AFTER LOSS OF OVARIAN-FUNCTION IN EXPERIMENTAL BEAGLE DOGS [J]. ENDOCRINOLOGY, 1986, 119 (06) : 2649 - 2654

[35] INFLAMMATION-MEDIATED OSTEOPENIA IN THE RAT - A NEW ANIMAL-MODEL FOR PATHOLOGICAL LOSS OF BONE MASS [J]. ENDOCRINOLOGY, 1984, 115 (01) : 50 - 54

[36] MINNE HW, 1986, J BONE MINERAL RE S1, V1

[37] PHARMACOLOGY OF ANTIANDROGENS [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (5B) : 885 - 895

[38] NEUMANN F, 1974, HDB EXPT PHARM

[39] NUTIK G, 1974, P SOC EXP BIOL MED, V146, P265

[40] PARVIZI S, 1985, ACTA ENDOCRINOL S267, V108

[31] LINDSAY R, 1980, LANCET, V2, P1151

[32] LINDSAY R, 1978, POSTGRAD MED J, V54, P50

[33] METABOLISM OF TAMOXIFEN AND ITS UTEROTROPHIC ACTIVITY [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (15) : 2787 - 2794

[34] OSTEOBLASTIC INSUFFICIENCY IS RESPONSIBLE FOR MAINTENANCE OF OSTEOPENIA AFTER LOSS OF OVARIAN-FUNCTION IN EXPERIMENTAL BEAGLE DOGS [J]. ENDOCRINOLOGY, 1986, 119 (06) : 2649 - 2654

[35] INFLAMMATION-MEDIATED OSTEOPENIA IN THE RAT - A NEW ANIMAL-MODEL FOR PATHOLOGICAL LOSS OF BONE MASS [J]. ENDOCRINOLOGY, 1984, 115 (01) : 50 - 54

[36] MINNE HW, 1986, J BONE MINERAL RE S1, V1

[37] PHARMACOLOGY OF ANTIANDROGENS [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1986, 25 (5B) : 885 - 895

[38] NEUMANN F, 1974, HDB EXPT PHARM

[39] NUTIK G, 1974, P SOC EXP BIOL MED, V146, P265

[40] PARVIZI S, 1985, ACTA ENDOCRINOL S267, V108